The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.


Updates from The Motley Fool

Latest updates on GlaxoSmithKline from Fool.com.


Stock Performance

GSK vs. S&P 500 | 2 Year Performance
View Interactive GSK Charts
Sponsored by

Key Data Points

Primary metrics and data points about GlaxoSmithKline.
Current Price: $45.07
Prev Close: $45.18
Open: $45.19
Bid: $45.00
Ask: $45.34
Day's Range: $44.85 - $45.38
52wk Range: $37.24 - $45.49
Volume: 2,978,330
Avg Vol 3,968,479
Market Cap: $109.74B
P/E (ttm): 25.97
EPS (ttm): $1.74
Div & Yield: $2.33 (4.8%)

Company Rating

What our community thinks about GlaxoSmithKline.
CAPS Rating 3 out of 5
 
1414 Outperform
86 Underperform
CAPS All Stars
 
348 Outperform
23 Underperform

How do you think GlaxoSmithKline will perform against the market?



You pick for GlaxoSmithKline is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for GlaxoSmithKline.

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers